
Vogliquin M 500mg/0.2mg Tablet SR
Marketer
Vats Biotech Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Vogliquin M 500mg/0.2mg Tablet SR
Diabetol Duo 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects, such as nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are generally transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can offer strategies to manage or treat bothersome side effects. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.
Uses of Vogliquin M 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogliquin M 500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; refrain from chewing, crushing, or fracturing it. The Vogliquin M 500mg/0.2mg sustained-release tablet should be administered with a meal.
Common Side effects of Vogliquin M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vogliquin M 500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vogliquin M 500mg/0.2mg Extended-Release tablets with food.
How Vogliquin M 500mg/0.2mg Tablet SR works:
Vogliquin M 500mg/0.2mg extended-release tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Vogliquin M 500mg/0.2mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Vogliquin M 500mg/0.2mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vogliquin M 500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Vogliquin M 500mg/0.2mg extended-release tablets typically do not impair driving ability. Nevertheless, individuals taking this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Vogliquin M 500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Vogliquin M 500mg/0.2mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vogliquin M 500mg/0.2mg sustained-release tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vogliquin M 500mg/0.2mg Tablet SR :
Should you forget to take a Vogliquin M 500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogliquin M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
